300253 卫宁健康
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.5276.6312.1287.86111.900
总资产报酬率 ROA (%)0.3544.3731.4185.5808.788
投入资产回报率 ROIC (%)0.4235.2671.6866.6419.835

边际利润分析
销售毛利率 (%)41.35045.00243.68946.34854.076
营业利润率 (%)1.41610.7931.27713.62324.339
息税前利润/营业总收入 (%)3.70812.3862.52914.86124.349
净利润/营业总收入 (%)1.81510.0400.47712.86222.303

收益指标分析
经营活动净收益/利润总额(%)383.124104.088685.88099.50291.531
价值变动净收益/利润总额(%)-81.411-6.153-234.98231.22112.183
营业外收支净额/利润总额(%)-1.278-0.201-2.493-0.400-1.010

偿债能力分析
流动比率 (X)3.0662.8422.7253.2782.632
速动比率 (X)2.9772.7772.6633.1732.528
资产负债率 (%)32.00833.54434.45530.98722.171
带息债务/全部投入资本 (%)17.34317.50818.97517.723--
股东权益/带息债务 (%)464.342458.427413.878450.8941,216.498
股东权益/负债合计 (%)212.341198.318189.610219.552336.734
利息保障倍数 (X)1.6057.6711.97211.50496.229

营运能力分析
应收账款周转天数 (天)158.364116.15795.36484.5840.000
存货周转天数 (天)30.90221.54523.83231.8820.000